PolyU recognized at CES 2027 Innovation Awards

PolyU develops Tumour Heterogeneity Index to precisely identify breast cancer patient drug response, achieving a 56% pathological complete response rate

PolyU develops quantum-tunnelling field-effect transistor to overcome barriers to integrated-circuit chip development

PolyU develops quantum-tunnelling field-effect transistor to overcome barriers to integrated-circuit chip development